Design Therapeutics (DSGN) Q2 2026 Earnings

28AprConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.34
-0.32
-0.3
-0.28

Details

Expected EPS
-0.328333
Actual EPS
-0.29
Surprise EPS
0.04
Surprise Percent
+11.68%

Description

Design Therapeutics (DSGN) has reported earnings of -0.29 per share for Q2 2026.

0 Comments

Share your thoughts